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Abstract 
A photosensitizing boron-containing porphyrin derivative denoted BOPP, which is selectively localised into mitochondria, has been 
tested on Namalwa cells, in each of two genetic onfigurations: p+ cells containing normal mtDNA and mitochondrial respiratory 
functions, or pO cells lacking mtDNA and devoid of mitochondrial oxidative phosphorylation. After short-term cellular uptake for 18 h, 
BOPP (30 /xg/ml) was not cytotoxic, but did show marked phototoxicity in Namalwa p+ cells, concomitant with substantial reduction 
of mitochondrial respiratory activity. After long-term (3 days or more) exposure to BOPP without light, growth of Namalwa p+ cells was 
inhibited at concentrations significantly above 30/xg/ml. At such concentrations BOPP was shown to have direct inhibitory effects on 
mitochondrial zide-sensitive r spiration of p+ cells. By contrast, BOPP showed neither cytotoxic nor phototoxic effects in pO cells. 
These results indicate functional mitochondria tobe a major cellular target in vivo after BOPP uptake and photoactivation. 
Keywords: Mitochondrion; Photosensitiser; Porphyrin; Cell killing; Oxidative stress; Human cultured cell 
In this paper, we report a novel cellular system that we 
have established in order to explore the relationship of 
oxidative stress to functional and genetic damage in mito- 
chondria. Central to this new approach is the use of a 
particular photosensitizing compound, a boronated por- 
phyrin [1] detailed below, which has been developed for 
therapeutic application in the treatment of tumours [2]. In 
general, photosensitizing compounds used in photody- 
namic therapy (PDT) are selectively taken up or retained 
by neoplastic ells in the patient and on photoactivation 
generate a flux of reactive oxygen species that kills the 
target cells (for review see Ref. [2]). The particular pho- 
toactivatable compound used in the present work is de- 
noted BOPP (a tetrakis-carborane-carboxylate ester of 2,4- 
bis-(a,fl-dihydroxyethyl) deuteroporphyrin IX) [1]. In the 
present context, BOPP was considered as potentially very 
useful because of its highly selective cellular localisation 
within mitochondria [3,4] recognised by confocal mi- 
croscopy and subcellular t~ractionation studies. In consider- 
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ing the potential use of BOPP as a mitochondrially o- 
calised photosensitizing compound for the controlled gen- 
eration of oxidative stress within mitochondria, we set out 
to establish whether mitochondria are the major functional 
target for photoactivated BOPP in intact cells 
We introduce here a simple and effective cellular sys- 
tem to address this question. This system involves a com- 
parison of the effects of BOPP on human cell lines in 
either the p+ state containing normal mtDNA and carry- 
ing out mitochondrial respiratory functions, or as p0 cells 
lacking mtDNA [5-7] and devoid of mitochondrial oxida- 
tive phosphorylation. As an adjunct to the cell viability 
experiments, we have tested the effects of including pyru- 
vate and uridine in the growth medium for experimentally 
treated p÷ cells. These supplements are required for the 
growth of vertebrate pO cells and other cells which have 
debilitated mitochondrial function (see Ref. [8]), such as 
anaerobically grown p+ cells [9]. Uridine is required since 
biosynthesis of pyrimidines at the level of dihydro-orotate 
dehydrogenase d pends upon a functional mitochondrial 
electron transport chain [10], while pymvate is thought o 
act as a generalised redox sink to allow reoxidation of 
pyridine nucleotides under conditions where NADH oxida- 
2 A.D. Munday et al./Biochimica et Biophysica Acta 1311 (1996) 1-4 
tion by the mitochondrial respiratory chain is significantly 
blocked [8,11]. Finally, we directly measured mitochon- 
drial respiration in intact human cells after exposure to 
BOPP and photoactivation. 
Human lymphoblastoid Namalwa p+ cells have been 
previously described [9]. Namalwa p0 cells (clone 12) 
were provided by Dr. F. Vaillant, following subcloning 
[12] of a p0 cell population [13]. Cells were maintained in
RPMI 1640 with l0 mM Hepes, 100 U/ml  penicillin, 100 
/~g/ml streptomycin, 5 /xM 2-mercaptoethanol and 10% 
(v/v)  foetal calf serum. Additionally, for p0 cells the 
medium contained uridine (50 /xg/ml) and pyruvate (1 
mM). Some experiments, as indicated, were carded out 
with p+ cells in RPMI 1640 medium supplemented with 
uridine and pyruvate as above. Cells were cultured in 7.5 
ml media in 25 cm 2 plastic tissue culture flasks (wrapped 
in aluminium foil to minimise unwanted exposure to ambi- 
ent light of cultures containing BOPP, where relevant) at 
37°C in an atmosphere of 5% CO2/95% air in a humidi- 
fied incubator. For routine propagation, cultures were split 
and growth medium replenished every 3-4 days. Growth 
of Namalwa cells was determined by inoculating cells at 
5 X 10 4 cells/ml and monitoring rowth by counting vi- 
able cells in portions of the culture using a haemocytome- 
ter in the presence of trypan blue. 
For assay of cytotoxicity of BOPP towards Namalwa 
cells, after short-term exposure (18 h) to different concen- 
trations of BOPP, cell growth was assayed after washing 
cells; exposure of cells to light was avoided. The results 
(data not shown) indicated that under these conditions 
there was little, if any, cytotoxicity of BOPP towards 
either Namalwa p+ cells (in the presence or absence of 
pyruvate and uridine) or p0 cells, up to 50/xg/ml  BOPP. 
There was a slight cytotoxicity observed at 100 /xg/ml 
BOPP for Namalwa p+ cells in the presence or absence of 
pyruvate and uridine. 
For analysis of the comparative phototoxic effects of 
BOPP on p+ and p0 cells a concentration f BOPP of 30 
/zg/ml was selected. Based on other studies on phototoxi- 
city of BOPP towards rat C6 glioma cells [14], this concen- 
tration of BOPP would lead to a dose-response curve 
across a convenient range of time of photoirradiation. 
Indeed, as shown in Fig. l, p+ cells in the absence of 
pyruvate and uridine showed significant loss of viability 
during exposure to intense light such that after 90 min 
photoirradiation there was a 50% reduction in viability. 
There appeared to be a reproducible plateau effect, with a 
slight further loss of colony survival up to 120 min irradia- 
tion. By contrast, p0 cells lacking functional mitochondria 
showed almost complete insensitivity to photosensitisation 
by BOPP. This provides strong evidence that the photo- 
toxic effects of BOPP require functional mitochondria, in
the case of Namalwa p+ cells there was some protective 
effect of pyruvate and uridine (Fig. 1), consistent with the 
inferred role of functional mitochondria s a target for 
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Fig. 1. Phototoxicity of BOPP after uptake into suspension Namalwa 
cells. BOPP was added directly to cultures of Namalwa cells at a cell 
density of about 5 X 105 cells/ml. After 18 h incubation, cells were 
centrifuged and washed with phosphate-buffered saline (PBS), finally 
resuspending cells in 10 ml of fresh growth medium. A portion of the 
cells was inoculated into 7.5 ml of fresh medium in a culture flask at a 
cell density 5 X 104 cells/ml. As in previous work [14], cells in the flask 
were exposed to light (800 gW/cm 2) on a light box containing a circular 
fluorescent globe (32 W), with Rosco 'supergel' no. 15 and no. 25 filters 
(Masson Photographics, Melbourne) interposed between the light source 
and the culture flasks to eliminate the transmission of light below 600 
nm. In addition, a 5-mm thick perspex sheet was placed between the 
filters and the flasks to minimise the effect of heat arising from the light 
source. After exposure to light, flasks were again wrapped in aluminium 
foil and cells allowed to grow for a further 3 days. Symbols as follows: 
/90 cells in the presence of pyrnvate and uridine (O); p+ cells in the 
presence of pyruvate and uridine (B); p+ cells in the absence of both 
pyruvate and uridine ( • ). Results are the mean of three experiments. Bar 
indicates the maximal variation observed between replicate measure- 
ments. In each case the control (100% viability) is taken as the viable 
count following exposure to BOPP without photoirradiation. 
Direct measurements of the effect of photosensitisation 
by BOPP on mitochondrial respiratory activity were under- 
taken by measurement of oxygen uptake of Namalwa p+ 
cells (Table 1). Using azide-sensitive oxygen uptake as a 
measure of mitochondrial respiratory activity in intact 
cells, the results showed that exposure of Namalwa p+ 
cells to 30/xg/ml  BOPP for 18 h without photoirradiation 
had no measurable effect on respiration. Following BOPP 
uptake and photoirradiation for 90 or 120 min, the mito- 
chondrial respiratory activity was inhibited by more than 
50%. This result indicates mitochondria to be a primary 
target of BOPP phototoxicity, correlated with the loss of 
viability of Namalwa p+ cells treated under similar condi- 
tions (Fig. 1). 
After short-term (18 h) uptake BOPP has no apparent 
impact on mitochondrial function or cell growth of Na- 
malwa p+ cells without photoactivation. At higher con- 
centrations and over long-term exposure, however, BOPP 
does have cytotoxic effects on Namalwa p+ cells (Fig. 2). 
Namalwa p+ cells continuously incubated with different 
concentrations of BOPP during propagation showed a 
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Table 1 
Decline in mitochondrial respiratory activity of Namalwa p+ cells after 
BOPP uptake and photoactivation 
Photoirradiation Corrected oxygen inhibition relative 
time (min) consumption (% of control) 
(nmol O/min/106 cells) 
Table 2 
Inhibition by BOPP of mitochondrial respiratory activity (azide-sensitive) 
in Namalwa p+ cells 
Concentration f Corrected oxygen Inhibition 
BOPP (/zg/ml) consumption by BOPP (%) 
(nmol O/min/106 cells) 
Control 1.6 0 0 2.3 0 
0 1.6 0 20 1.9 17 
90 0.7 56 40 1.2 48 
120 0.8 50 80 1.1 52 
Following uptake of BOPP (30 /xg/ml) for 18 h, Namalwa p+ cells 
were washed and photoirradiated for different times. Cellular espiration 
was measured using a Clark-type oxygen electrode in a micro-respiration 
cell supplied by Strathkelvin i struments (Glasgow, UK). Cellular oxygen 
uptake was measured using 250/xl portions of suspensions of Namalwa 
p+ cells in growth medium, the ,:ell density being in the range 1-6X 106 
viable cells/ml. Oxygen consumption rates were corrected for the mea- 
sured oxygen consumption (0.4 nmol O/min/106 cells) in the presence 
of sodium azide (1 mM) (non-mitochondrial). Therespiration apparatus 
was wrapped in aluminium foil to minimise xposure to ambient light. 
Control cells were exposed to neither BOPP nor light. Results are the 
mean of two experiments. 
dose-dependent i hibition of cell growth in the absence of 
pyruvate and uridine, particularly at concentrations of  
BOPP 40 / zg /ml  and above that was partially alleviated 
by supplementation f  the growth medium with pyruvate 
and uridine. Since po cells are unaffected (Fig. 2), it is 
inferred that BOPP, at high concentrations, does have 
some inhibitory effect on mitochondrial function, even 
without photoactivation. This was confirmed by measure- 
















Fig. 2. Cytotoxcity of BOPP (luring long-term exposure of suspension 
Namalwa cells. Cells were grown in the presence of different concentra- 
tions of BOPP for 3 days. Symbols as follows: p0 cells in the presence of
pyruvate and uridine (O): p+ cells in the presence of pyruvate and 
uridine (t2); p+ cells in the abscence of both pyruvate and uridine (zx). 
Results are the mean of two experiments. Bar indicates the maximal 
variation observed between replicate measurements. In each case the 
control (100% viability) is taken as the viable count following growth of 
cells in the absence of BOPP. 
Namalwa p+ cells were incubated in different concentrations of BOPP 
whilst measuring oxygen consumption. The micro-respiration chamber 
was protected from ambient light to avoid any photosensitisation effects. 
Respiration rates (determined as in Table 1) are corrected for oxygen 
consumption f control cells in the presence of 1 mM azide (0.6 nmol 
O/min/106 cells). Control ceils were exposed to neither BOPP nor light. 
Results are the mean of two experiments. 
respiration (Table 2). There was indeed a concentration-de- 
pendent inhibition of mitochondrial respiratory activity of 
Namalwa p+ cells by BOPP such that, at BOPP concen- 
trations of 40 /xg/ml  and above, there was about 50% 
inhibition of azide-sensitive oxygen consumption. This can 
account for the inhibition of cellular growth which is 
evident at 50 /xg /ml  BOPP and above (Fig. 2). 
On the basis that p0 cells lacking functional oxidative 
phosphorylation are minimally affected by BOPP, the pre- 
sent data clearly identify mitochondria s a major target 
for both cytotoxicity and phototoxicity of this porphyrin 
derivative. Possible functional targets for BOPP, without 
photoactivation, i  mitochondria, include respiratory chain 
enzymes (Table 2) and ATP synthase [15]. The flux of 
reactive oxygen species arising from the photoactivation f 
BOPP [2] would cause molecular damage to various com- 
ponents in mitochondria, including proteins, lipids and 
DNA, but this in itself may not be the immediate cause of 
cell death. Oxidative stress has been shown to be a key 
factor in the elicitation of the so-called mitochondrial 
permeability transition, which involves the opening of a 
non-specific pore across the mitochondrial membranes that 
triggers a cellular response culminating in cell death (re- 
viewed in Ref. [16]). The likelihood of phototoxic effects 
of BOPP on this pore is suggested by the previously 
demonstrated binding of porphyrin compounds to the mito- 
chondrial benzodiazepine r ceptor on the outer membrane 
[17]. Further studies are needed to clarify the detailed role 
of BOPP in binding to various mitochondrial targets and 
releasing reactive oxygen species on photoactivation. I ter- 
estingly, Yoneda et al. [18] have recently shown that p+ 
human cells cultured in an atmosphere of very high oxy- 
gen levels undergo cell killing, to which p0 cells are 
relatively immune, emphasising the role of functional 
mitochondria in cell death resulting from oxygen stress. 
Haematoporphyrin derivative (HpD) is one of several 
porphyrin preparations used in PDT [2]. HpD is a complex 
mixture of compounds and distributes into multiple cellu- 
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lar locations after uptake [3]. Recent detailed studies on the 
effects of photoactivated HpD on mitochondria [19,20] 
have extended the body of earlier data indicating that the 
biologically deleterious effects of porphyrin compounds 
after photoirradiation do involve mitochondria. Neverthe- 
less, the selective mitochondrial targeting of BOPP, that 
occurs in p+ cells as well as in p0 cells (Munday, A., 
Nagley, P. and Hill, J.S., unpublished ata), suggests that 
BOPP is a more powerful tool in probing mitochondrial 
involvement in cell death pathways than HpD. Indeed, 
recent studies have shown that the differential cytotoxic 
and phototoxic effects of HpD [14] on p+ and p0 cells are 
more complex than those reported here for BOPP (Gurung, 
R., Sriratana, A. and Nagley, P., unpublished ata). 
The system described in this paper which utilises cells 
defective in mitochondriai function should, therefore, pro- 
vide an excellent in vitro assay for screening porphyrins 
and other PDT sensitisers [21] for their potential clinical 
efficacy, particularly those that localise in mitochondria. 
Furthermore, in drawing attention here to the critical role 
that mitochondria play in cell killing, we can note that the 
development of new photosensitisers that are specifically 
targeted to mitochondria will be enhanced by placing 
emphasis on their ability to inhibit mitochondrial energy 
metabolism as well as to activate the mitochondrial perme- 
ability transition that efficiently leads to a cell death 
response. 
The recognition of BOPP as a mitochondrially targeted 
photosensitiser suggests its use as novel tool to inflict 
oxidative stress on mitochondria n a relatively simple and 
readily controlled manner. BOPP therefore has the poten- 
tial to be used as a photosensitiser that mimics the oxida- 
tive stress within mitochondria characteristic of human 
ageing [11,22,23]. Future studies on the induction of 
mtDNA mutations in photosensitised cells, as well as 
analysis of the inactivation of individual mitochondrial 
enzymes, would be highly informative. 
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